Category: Sterilization / Calibration

Mork lands $1.4 million

August 23, 2010 by MedCity News

Industrial sterilization and cleaning company Mork Process Inc. raised $1.4 million in equity of an expected $2 million funding round, according to a Securities & Exchange Commission filing.

The Stow, Ohio-based company specializes in process cleaning and sterilizing equipment for manufacturers in the pharmaceutical, biotechnology and food industries. Its specialty is “clean-in-place” and “sterilize-in-place” technologies used to sterilize the inside of large mixing containers.

Steris down $45 million for Q1 due to hefty customer retention program

August 3, 2010 by MedCity News

Steris Corp. (NYSE:STE) lost $45 million in its fiscal first quarter, thanks to setting aside $110 million to cover a rebate program in a bid to hold on to customers of its flagship sterilization technology.

The Mentor, Ohio-based infection prevention and decontamination technology maker said more customers than expected may use rebates to switch to System 1E — a liquid chemical sterilizing system used by hospitals, surgical centers and other healthcare facilities to sterilize heat-sensitive medical instruments, such as endoscopes — from the original Steris sterilizer, called System 1.

Steris to give shareholders vote on executive pay

May 19, 2010 by MedCity News

By Mary Vanac

Steris Corp. (NYSE:STE) will give shareholders a say on the company’s executive compensation program at its July annual meeting.

The Mentor, Ohio-based sterilization products maker is asking shareholders to approve a “nonbinding, advisory proposal” on executive pay. Such votes often are called "Say on Pay" proposals; proponents say they strengthen the relationship between a company and its shareholders. Opponents say the proposals do little to affect excessive executive pay.

Steris to spend $11 million on HQ expansion

May 11, 2010 by MedCity News

By Mary Vanac

STERIS Corp. (NYSE:STE) is investing $11 million in a headquarters expansion to create an interactive showcase for its health technologies that it hopes will change the way it works with customers.

STERIS Corp. raises FY2010 profits despite sales slide

May 6, 2010 by MedCity News

By Mary Vanac

STERIS Corp. (NYSE: STE) continued its quest to make operations more efficient in fiscal 2010, leading to higher profits for the year. However, like so many other companies dealing with market uncertainties, revenues fell.

Steris Corp. settles FDA beef

April 20, 2010 by MedCity News

By Mary Vanac

Steris Corp. (NYSE:STE) settled its beef with the Food & Drug Administration, addressing the “violating device” status of its System 1 liquid chemical sterilizer and setting up a transition plan that will enable U.S. customers — mostly hospitals and surgical centers — to trade in their System 1s for rebates.

Steris wins FDA nod for new sterilization system

April 7, 2010 by MedCity News

By Mary Vanac